Micronutrient risk with GLP-1 receptor and dual incretin agonists in obesity: Mechanistic pathways, clinical signals, and a monitoring framework

Obesity Pillars · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles